Sector
PharmaceuticalsOpen
₹426.25Prev. Close
₹424.15Turnover(Lac.)
₹72.74Day's High
₹427.85Day's Low
₹373.6552 Week's High
₹1,017.8552 Week's Low
₹373.65Book Value
₹175.62Face Value
₹10Mkt Cap (₹ Cr.)
327.99P/E
17.95EPS
22.11Divi. Yield
0.5Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 8.26 | 8.26 | 8.26 | 8.26 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 120.18 | 97.83 | 77.98 | 57.56 |
Net Worth | 128.44 | 106.09 | 86.24 | 65.82 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 122.45 | 69.47 | 55.53 | 52.45 |
yoy growth (%) | 76.26 | 25.11 | 5.86 | 14.99 |
Raw materials | -53.31 | -36.08 | -32.29 | -33.97 |
As % of sales | 43.53 | 51.94 | 58.15 | 64.76 |
Employee costs | -12.04 | -10.02 | -3.07 | -2.76 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 39.08 | 7.62 | 3.91 | 3.49 |
Depreciation | -2.1 | -1.74 | -0.9 | -0.79 |
Tax paid | -9.98 | -2.04 | -1.07 | -1.15 |
Working capital | 11.11 | 5.04 | 2.13 | 6.97 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 76.26 | 25.11 | 5.86 | 14.99 |
Op profit growth | 284.77 | 62.05 | 21.72 | 40.81 |
EBIT growth | 323.54 | 51.95 | 26.47 | 38.72 |
Net profit growth | 363.96 | 118.42 | 21.51 | 35.56 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 156.45 | 164.07 | 144 | 152.81 | 142.24 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 156.45 | 164.07 | 144 | 152.81 | 142.24 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 3.91 | 1.75 | 1.94 | 1.02 | 0.79 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.65 | 92.31 | 3,95,326.43 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,537.95 | 78.57 | 1,73,562.03 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,498.35 | 24.58 | 1,21,022.9 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,312.75 | 20.48 | 1,09,550.72 | 1,200.7 | 0.61 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,226.65 | 57.31 | 1,09,199.59 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Naresh Kumar Singla
Managing Director
Suresh Chand Singla
Non-Exec & Non-Independent Dir
Manju Singla
Company Sec. & Compli. Officer
Charanjit Singh
Non-Exec & Non-Independent Dir
Supriya Singla
Chairman & Independent Directo
Rohit Jain
Independent Director
Abhishek Agarwal
Whole-time Director
Raja Singla
Independent Director
Dhairya Madan
Independent Director
Brijesh Kumar Singh
Whole Time Director
Shivom Singla
Whole Time Director
Udit Singla
A-902 A RIICO Industrial Area,
Phase III Alwar District,
Rajasthan - 301019
Tel: 91-011-27355742/27674615
Website: http://www.titanbiotechltd.com
Email: hrd@titanbiotechltd.com
Beetal House 99,
Madangir Behind LSC, Nr Dada Harsukhdar,
Delhi - 110062
Tel: 91-011-29961281
Website: -
Email: beetalrta@gmail.com
Summary
Titan Biotech Ltd., the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms. They are p...
Read More
Reports by Titan Biotech Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.